Concepedia
Statistics
Publications
29
Citations
2.6K
H-Index
22
Active since
1991
Affiliations
Pfizer (United States)(Current)
Duquesne University
Eli Lilly (United States)
Experimental Station
Purdue University West Lafayette
Rajesh Devraj is an author at Pfizer (United States) specializing in pharmacology, medicinal chemistry, and pharmacy.
Publications per year
1991–2021
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes, Julian Blagg, David A. Price et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 973 citations
Pharmacy, Pharmacology, Toxicology +14
Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition
Daniel L. Flynn, J. Z. CRICH, Rajesh Devraj et al. · Journal of the American Chemical Society · 1997 · 211 citations
Pharmacy, Chemical Engineering, Chemistry +17
Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
Robert Hughes, Todd Bosanac, Xianrong Mao et al. · Cell Reports · 2021 · 191 citations · Full text
Life Sciences, Neurobiology, Neuroscience +17
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
Todd Bosanac, Robert Hughes, Thomas M. Engber et al. · Brain · 2021 · 149 citations · Full text
Life Sciences, Neuroscience, Pharmacology +13
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons
Yo Sasaki, Thomas M. Engber, Robert Hughes et al. · Experimental Neurology · 2020 · 125 citations · Full text
Life Sciences, Molecular Biology, Neuroscience +14
1–5 of 29